• InspireMD held its annual shareholder meeting on June 3, 2026.
• Shareholders backed an amendment to raise authorized common shares to 250,000,000 from 150,000,000.
• The charter amendment was executed on June 3, 2026, taking effect upon filing of the certificate of amendment.
• Shareholders re-elected three directors, approving the board slate.
• Shareholders ratified Kesselman & Kesselman, a PwC International member firm, as independent auditor for fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InspireMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-027045), on June 03, 2026, and is solely responsible for the information contained therein.